Altered Expression of Programmed Death-1 Receptor (PD-1) and Its Ligand PD-L1, PD-L2 after Neo-Adjuvant Chemotherapy in Lung Cancer

被引：0
|
作者：
Sun, W. [1 ]
Ma, K. [1 ]
Wang, X. [1 ]
Liu, Y. [1 ]
He, H. [1 ]
Guo, Y. [1 ]
机构：
[1] Jinlin Univ, Hosp 1, Changchun, Jilin, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Programmed death-ligand 1; neo-adjuvant chemotherapy; lung cancer;
D O I：
10.1016/j.jtho.2017.09.303
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-006
引用
收藏
页码：S1996 / S1996
页数：1
相关论文
共 50 条
  • [41] Gene expression of programmed cell death (PD-1) and its ligand, PD-L1, in primary epithelial ovarian cancer
    Talukdar, S.
    Cepela, J.
    Chang, Z.
    Zhang, Y.
    Grad, A.
    Mullany, S. A.
    Starr, T.
    Winterhoff, B.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 254 - 254
  • [42] EXPRESSION OF PD-1, PD-L1 AND PD-L2 IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ITS CLINIC RELATIONSHIP
    Geng, S.
    Weng, J.
    Deng, C.
    Li, M.
    Lu, Z.
    Wu, P.
    Huang, X.
    Lai, P.
    Du, X.
    LEUKEMIA RESEARCH, 2017, 55 : S112 - S112
  • [43] Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
    Bertsias, G.
    Raptopoulou, A.
    Coutala, E.
    Mamoulaki, M.
    Kritikos, H.
    Sidiropoulos, P.
    Boumpas, D. T.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S55 - S55
  • [44] Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
    G Bertsias
    A Raptopoulou
    E Coutala
    M Mamoulaki
    H Kritikos
    P Sidiropoulos
    DT Boumpas
    Arthritis Research & Therapy, 7
  • [45] Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis
    Alexandra Giatromanolaki
    Ioannis M. Koukourakis
    Konstantina Balaska
    Achilleas G. Mitrakas
    Adrian L. Harris
    Michael I. Koukourakis
    Medical Oncology, 2019, 36
  • [46] Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer
    Calles, Antonio
    Liao, Xiaoyun
    Sholl, Lynette M.
    Rodig, Scott J.
    Freeman, Gordon J.
    Butaney, Mohit
    Lydon, Christine
    Dahlberg, Suzanne E.
    Hodi, F. Stephen
    Oxnard, Geoffrey R.
    Jackman, David M.
    Jaenne, Pasi A.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) : 1726 - 1735
  • [47] AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer
    Spirina, L. V.
    Avgustinovich, A. V.
    Afanas'ev, S. G.
    Kondakova, I. V.
    Volkov, M. Yu.
    Dobrodeev, A. Yu.
    Boronkina, A. I.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2020, 170 (01) : 75 - 78
  • [48] Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis
    Giatromanolaki, Alexandra
    Koukourakis, Ioannis M.
    Balaska, Konstantina
    Mitrakas, Achilleas G.
    Harris, Adrian L.
    Koukourakis, Michael I.
    MEDICAL ONCOLOGY, 2019, 36 (09)
  • [49] AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer
    L. V. Spirina
    A. V. Avgustinovich
    S. G. Afanas’ev
    I. V. Kondakova
    M. Yu. Volkov
    A. Yu. Dobrodeev
    A. I. Boronkina
    Bulletin of Experimental Biology and Medicine, 2020, 170 : 75 - 78
  • [50] PD-L1 and PD-L2 expression in colorectal cancer
    Zeynep, Ozgul
    Funda, Canaz
    Evrim, Yilmaz
    Deniz, Arik
    Bulent, Yildiz
    Fatih, Yasar. N.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2023, 66 (01) : 31 - 37
12345